Cancer Research SABCS  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 7191, September 1, 2008. doi: 10.1158/0008-5472.CAN-07-6198
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugahara, K. N.
Right arrow Articles by Miyasaka, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugahara, K. N.
Right arrow Articles by Miyasaka, M.

Tumor Microenvironment

Chondroitin Sulfate E Fragments Enhance CD44 Cleavage and CD44-Dependent Motility in Tumor Cells

Kazuki N. Sugahara1, Takako Hirata2, Toshiyuki Tanaka1, Shinji Ogino3, Mitsuhiro Takeda3, Hiroaki Terasawa3, Ichio Shimada3, Jun-ichi Tamura4, Gerdy B. ten Dam5, Toin H. van Kuppevelt5 and Masayuki Miyasaka1

1 Laboratory of Immunodynamics, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine and 2 The 21st Century COE Program, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan; 3 The Laboratory of Physical Chemistry, Graduate School of Pharmaceutical Science, University of Tokyo, Tokyo, Japan; 4 Department of Regional Environment, Faculty of Regional Sciences, Tottori University, Tottori, Japan; and 5 Department of Biochemistry, Nijmegen Center for Molecular Life Sciences, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands

Requests for reprints: Masayuki Miyasaka, Laboratory of Immunodynamics, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine C8, 2-2, Yamada-oka, Suita 565-0871, Japan. Phone: 81-6-6879-3972; Fax: 81-6-6879-3979; E-mail: mmiyasak{at}orgctl.med.osaka-u.ac.jp.

Key Words: Chondroitin Sulfate E fragments • CD44 • cleavage • tumor cell • migration

During tumor cell invasion, certain extracellular matrix (ECM) components such as hyaluronan (HA) are degraded into small oligosaccharides, which are detected in patients. We previously reported that such HA oligosaccharides induce the proteolytic cleavage of an ECM-binding molecule CD44 from tumor cells and promote tumor cell migration in a CD44-dependent manner. Here, we report that chondroitin sulfate E (CSE), another component of the tumor ECM, strongly enhances CD44 cleavage and tumor cell motility when degraded into oligosaccharides. CSE and its degradation products were detected in pancreatic ductal adenocarcinoma. In CD44-expressing pancreatic tumor cells, degraded forms of CSE but not intact CSE enhanced CD44 cleavage; enzymatic digestion of such low-molecular weight CSE (LMW-CSE) abrogated this enhancement. Among the LMW-CSE preparations examined, 3-kDa CSE most potently induced CD44 cleavage. Nuclear magnetic resonance analysis showed that the 3-kDa-CSE bound to CD44, and that blocking such binding abrogated the CD44 cleavage induction. LMW-CSE also induced prominent filopodia formation and cytoskeletal changes in tumor cells; these effects were also abrogated by blocking the LMW-CSE binding to CD44. Chemically synthesized CSE hexasaccharides also enhanced the CD44 cleavage and tumor cell motility in a CD44-dependent manner. We conclude that the degraded forms of CSE modulate cell adhesion and migration by interacting with tumor-cell CD44, suggesting that the degradation products of tumor-associated ECMs that interact with CD44 play a significant role in CD44-mediated tumor progression. [Cancer Res 2008;68(17):7191–9]




This article has been cited by other articles:


Home page
GlycobiologyHome page
Basappa, S. Murugan, K. N Sugahara, C. M. Lee, G. B ten Dam, T. H van Kuppevelt, M. Miyasaka, S. Yamada, and K. Sugahara
Involvement of chondroitin sulfate E in the liver tumor focal formation of murine osteosarcoma cells
Glycobiology, July 1, 2009; 19(7): 735 - 742.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Li, G. B. ten Dam, S. Murugan, S. Yamada, T. Hashiguchi, S. Mizumoto, K. Oguri, M. Okayama, T. H. van Kuppevelt, and K. Sugahara
Involvement of Highly Sulfated Chondroitin Sulfate in the Metastasis of the Lewis Lung Carcinoma Cells
J. Biol. Chem., December 5, 2008; 283(49): 34294 - 34304.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.